Law360, New York (July 01, 2009) -- The U.S. Food and Drug Administration has required Pfizer Inc. and GlaxoSmithKline PLC to put boxed warnings on their smoking-cessation aids amid reports linking the medications to suicides.
The FDA said Wednesday that Pfizer's Chantix, or varenicline, and GSK's Zyban, or bupropion, will now carry boxed warnings and have patient medication guides highlighting the risks of serious neuropsychiatric...
